Navigation Links
Antisense gene specific therapy for Ebola virus

Professor Sina Bavari and team from the U.S. Army Medical Research Institute of Infectious Diseases have found that antisense genetic sequence of the Ebola virus could help protection and treatment of humans // from wild strains of Ebola virus. This therapy is very important and still more has to be done as this Ebola virus offers a great threat of bioterrorism. The results of this research work are published in the Journal Public Library of Science Pathogens.

Ebola virus causes Viral Hemorrhagic Syndrome causing a very high increase of virus in blood leading to an ineffective immunological protection by the host against the virus leading necrosis. Morbidity and mortality is very high and varies according to the strain involved and no effective treatment has been found against the virus and interestingly virus has been isolated from the semen of infected person.

Antisense drugs binds to the replication site of the virus and due to the mismatch pairing it does not lead to replication of virus causing the reduction of the virus. A Combination of three Antisense Phosphorodiamidate Morpholino Oligomers (PMOs) was first tested on laboratory mice followed by experiments on guinea pigs and rhesus monkeys and the researchers found that the Antisense PMOs effectively inhibits the growth of the virus and the researchers are planning to further expand their study on antisense PMOs against Ebola virus.


'"/>




Page: 1

Related medicine news :

1. Gene testing kit specific for Doctors
2. Dental appointment fear: is it gender specific?
3. Child specific HIV drugs and laboratory tests should be developed
4. Acupuncture May Help Chemotherapy Side Effects
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. Distraction therapy found very effective in postoperative patients
7. Acupuncture superseeds massage therapy for short term relief of pain
8. Ovarian cancer in relationship with Hormone therapy
9. New therapy better at increasing bone density
10. Gene therapy - Aim to improve blood flow
11. Gene therapy restores sight
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market leader ... led by Eastside Partners, with participation from existing investor Martin Ventures. The ... accelerate its technology and product roadmap. , “Jvion is experiencing significant ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 Acquisition Expands ... Product Development Capabilities in North America ... . Indegene ( http://www.indegene.com ), ... acquisition of Skura Corporation,s life science business. Skura,s ... sales enablement technology for life science organizations and ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
Breaking Medicine Technology: